Shares of Sernova Corp. (TSE:SVA - Get Free Report) were down 4.5% during trading on Friday . The stock traded as low as C$0.21 and last traded at C$0.21. Approximately 56,087 shares were traded during mid-day trading, a decline of 64% from the average daily volume of 157,444 shares. The stock had previously closed at C$0.22.
Sernova Price Performance
The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of 16.55. The business's 50-day simple moving average is C$0.23 and its two-hundred day simple moving average is C$0.25. The firm has a market cap of C$68.32 million, a price-to-earnings ratio of -1.62 and a beta of 1.35.
About Sernova
(
Get Free Report)
Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.
See Also
Before you consider Sernova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.
While Sernova currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
